TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380,160 | -6.5% | 24,574 | -5.0% | 0.09% | -5.1% |
| Q2 2023 | $406,528 | -27.5% | 25,877 | -24.0% | 0.10% | -33.8% |
| Q1 2023 | $560,864 | +18.4% | 34,033 | +12.1% | 0.15% | 0.0% |
| Q4 2022 | $473,600 | +16.9% | 30,359 | -2.8% | 0.15% | -3.3% |
| Q3 2022 | $405,000 | +38.2% | 31,249 | +49.8% | 0.15% | +34.2% |
| Q2 2022 | $293,000 | +79.8% | 20,859 | +83.1% | 0.11% | +86.9% |
| Q1 2022 | $163,000 | – | 11,395 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |